BTC $58,971 +5.52% ETH $1,657 +5.91% USDT $0.9984 -0.04% BNB $538.71 +6.03% USDC $0.9992 -0.03% XRP $0.9150 +5.32% SOL $68.81 +4.68% FIGR_HELOC $1.07 +3.39% TRX $0.3037 +1.35% HYPE $59.95 +5.89% ZEC $783.69 +11.87% XMR $483.37 +12.45% DOGE $0.0540 +5.04% LEO $9.12 +0.09% WBT $56.65 +4.55% LINK $8.52 +5.61% USDS $1.00 +0.02% ADA $0.1414 +4.58% USDE $0.9986 0.00% XLM $0.1269 +4.91%
Market cap:$2.05T +2.13%
24h volume:$83.65B
BTC dominance:57.7%
ETH dominance:9.8%
Active coins:21,341
Fear & Greed:11 · Extreme Fear
Press release

Cypherpunk Technologies to Report Third Quarter 2026 Financial Results on November 16, 2026

Cypherpunk Technologies to Report Third Quarter 2026 Financial Results on November 16, 2026 PR Newswire
Press release: This announcement was written by the company involved and distributed by PR Newswire. CFDBloger did not write or verify it and does not endorse any project, token or offer mentioned. Nothing here is financial advice — do your own research.

CAMBRIDGE, Mass., Nov. 10, 2026 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) ("Cypherpunk"), a privacy technology company, today announced it will report third quarter 2026 financial results on Monday, November 16, 2026. The Company will discuss the results in a live audio event hosted on X via X Spaces at 9:00 a.m. ET. 

The discussion will be publicly accessible in real time to all listeners at https://x.com/cypherpunk, where the live event will appear at the scheduled time. A replay will be available on the Company's X profile and on the investor relations section of the Company's website at cypherpunk.com following the event. 

About Cypherpunk
Cypherpunk Technologies is a privacy technology company. The Company's mission is to advance technologies that guarantee privacy for humans on the internet. Cypherpunk pursues this mission through three primary strategies: mining Zcash through Cypherpunk Mining; accumulating Zcash through open market purchases; and investing in, acquiring, and building technologies that push the frontier of privacy forward. Additionally, through its subsidiary Leap Therapeutics, the Company is developing novel therapies for patients with cancer by continuing the development of sirexatamab and FL-501. For more information about the Company, visit our websites at http://www.cypherpunk.com and  http://www.leaptx.com or view our public filings with the SEC that are available via EDGAR at http://www.sec.gov. 

CONTACT:
Douglas E. Onsi
President & Chief Executive Officer
Cypherpunk Technologies Inc.
617-714-0360

For Investors:
Matthew DeYoung
Investor Relations
Argot Partners
212-600-1902

For Media:
Jacqueline Ortiz Ramsay
954-294-3249
 

SOURCE Cypherpunk Technologies Inc.

View the original release on PR Newswire ↗

Keep reading

More crypto news